Skip to content

Analgesic effects of Liposomal bupivacaine vs Bupivacaine Hydrochloride for PENG block in patients undergoing hip fracture surgery

Analgesic effects of Liposomal bupivacaine vs Bupivacaine Hydrochloride for PENG block in patients undergoing hip fracture surgery

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077758
Enrollment
Unknown
Registered
2023-11-17
Start date
2023-11-18
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip fracture

Interventions

LBgroup:Application of liposome bupivacaine for nerve block anesthesia, specific local anesthetic dosage: 20 mL 266 mg liposome bupivacaine+10 mL 0.9% physiological saline, a total of 30 mL
B Group:Application of bupivacaine hydrochloride for nerve block anesthesia, specific local anesthetic dosage: 0.5% bupivacaine hydrochloride 30 mL

Sponsors

lianyung hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 86 Years

Inclusion criteria

Inclusion criteria: The American Society of Anesthesiologists (ASA) is classified as Grade II or III, with a Body Mass Index (BMI) of 18-30 kg/m2 and an age range of 18-86 years old. The relevant informed consent form was signed one day before surgery.

Exclusion criteria

Exclusion criteria: Patients with a history of local anesthesia allergy, skin infection or damage at the puncture site, severe coagulation dysfunction, cognitive or mental disorders who do not cooperate,

Design outcomes

Primary

MeasureTime frame
NRS scores;

Secondary

MeasureTime frame
Muscle strength grading;

Countries

China

Contacts

Public ContactWang Jing

lianyungang hospital of TCM

1161880131@qq.com+86 189 6132 2716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026